<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Smith IN</submitter><funding>Ambrose Monell Foundation</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Ohio Supercomputing Center</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>4175-4190</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9472802</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(17)</volume><pubmed_abstract>The phosphatase and tensin homologue deleted on chromosome 10 (&lt;i>PTEN&lt;/i>) tumor suppressor gene encodes a tightly regulated dual-specificity phosphatase that serves as the master regulator of PI3K/AKT/mTOR signaling. The carboxy-terminal tail (CTT) is key to regulation and harbors multiple phosphorylation sites (Ser/Thr residues 380-385). CTT phosphorylation suppresses the phosphatase activity by inducing a stable, closed conformation. However, little is known about the mechanisms of phosphorylation-induced CTT-deactivation dynamics. Using explicit solvent microsecond molecular dynamics simulations, we show that CTT phosphorylation leads to a partially collapsed conformation, which alters the secondary structure of PTEN and induces long-range conformational rearrangements that encompass the active site. The active site rearrangements prevent localization of PTEN to the membrane, precluding lipid phosphatase activity. Notably, we have identified phosphorylation-induced allosteric coupling between the interdomain region and a hydrophobic site neighboring the active site in the phosphatase domain. Collectively, the results provide a mechanistic understanding of CTT phosphorylation dynamics and reveal potential druggable allosteric sites in a previously believed clinically undruggable protein.</pubmed_abstract><journal>Journal of chemical information and modeling</journal><pubmed_title>Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.</pubmed_title><pmcid>PMC9472802</pmcid><funding_grant_id>PCCF0020</funding_grant_id><funding_grant_id>R01 GM139297</funding_grant_id><funding_grant_id>1K99GM143552-01</funding_grant_id><funding_grant_id>K99 GM143552</funding_grant_id><funding_grant_id>T32 CA059366</funding_grant_id><funding_grant_id>P41 GM103712</funding_grant_id><funding_grant_id>T32 5T32CA59366-22</funding_grant_id><funding_grant_id>P41GM103712</funding_grant_id><pubmed_authors>Dawson JE</pubmed_authors><pubmed_authors>Smith IN</pubmed_authors><pubmed_authors>Thacker S</pubmed_authors><pubmed_authors>Bahar I</pubmed_authors><pubmed_authors>Krieger J</pubmed_authors><pubmed_authors>Eng C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.</name><description>The phosphatase and tensin homologue deleted on chromosome 10 (&lt;i>PTEN&lt;/i>) tumor suppressor gene encodes a tightly regulated dual-specificity phosphatase that serves as the master regulator of PI3K/AKT/mTOR signaling. The carboxy-terminal tail (CTT) is key to regulation and harbors multiple phosphorylation sites (Ser/Thr residues 380-385). CTT phosphorylation suppresses the phosphatase activity by inducing a stable, closed conformation. However, little is known about the mechanisms of phosphorylation-induced CTT-deactivation dynamics. Using explicit solvent microsecond molecular dynamics simulations, we show that CTT phosphorylation leads to a partially collapsed conformation, which alters the secondary structure of PTEN and induces long-range conformational rearrangements that encompass the active site. The active site rearrangements prevent localization of PTEN to the membrane, precluding lipid phosphatase activity. Notably, we have identified phosphorylation-induced allosteric coupling between the interdomain region and a hydrophobic site neighboring the active site in the phosphatase domain. Collectively, the results provide a mechanistic understanding of CTT phosphorylation dynamics and reveal potential druggable allosteric sites in a previously believed clinically undruggable protein.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T01:56:40.075Z</modification><creation>2025-04-04T20:28:51.946Z</creation></dates><accession>S-EPMC9472802</accession><cross_references><pubmed>36001481</pubmed><doi>10.1021/acs.jcim.2c00441</doi></cross_references></HashMap>